APO IMA 400 Pill - orange capsule/oblong, 17mm
Pill with imprint APO IMA 400 is Orange, Capsule/Oblong and has been identified as Imatinib Mesylate 400 mg. It is supplied by Apotex Corp.
Imatinib is used in the treatment of Chronic Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Chronic Eosinophilic Leukemia; Dermatofibrosarcoma Protuberans; Gastrointestinal Stromal Tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO IMA 400
Imatinib Mesylate
- Imprint
- APO IMA 400
- Strength
- 400 mg
- Color
- Orange
- Size
- 17.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apotex Corp.
- Inactive Ingredients
-
silicon dioxide,
crospovidone,
magnesium stearate,
hypromellose 2910 (5 mPa.s),
hydroxypropyl cellulose (type l),
ferric oxide red,
ferric oxide yellow,
polyethylene glycol 8000
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 60505-2901 | Apotex Corp. |
| 42291-0352 (Discontinued) | AvKare, Inc. |
More about imatinib
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (46)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.